Lipid formulations for nucleic acid delivery

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8058069
SERIAL NO

12424367

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARBUTUS BIOPHARMA CORPORATION100-8900 GLENLYON PARKWAY BURNABY BRITISH COLUMBIA V5J 5J8 CANADA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jeffs, Lloyd Delta, CA 17 1526
Lam, Kieu Surrey, CA 14 902
MacLachlan, Ian Mission, CA 90 7658
Palmer, Lorne Vancouver, CA 16 1539
Yaworski, Edward Maple Ridge, CA 12 902

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation